sb 206553 has been researched along with Seizures in 1 studies
SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Upton, N | 1 |
| Stean, T | 1 |
| Middlemiss, D | 1 |
| Blackburn, T | 1 |
| Kennett, G | 1 |
1 other study available for sb 206553 and Seizures
| Article | Year |
|---|---|
Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
Topics: Animals; Drug Interactions; Electric Stimulation; Indoles; Male; Mice; Pentylenetetrazole; Pyridines | 1998 |